secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
CIK:        0000917520
Form:       8-K
Filed at:   2025-05-13T23:59:59+00:00
Accession:  0000917520-25-000052
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integra LifeSciences shareholders approve 2.2M share increase in equity plan; chairman transitions to non-executive role
--------------------------------------------------------------------------------

- Stockholders approved Amendment No. 2 to increase shares under equity plan by 2.2M, to 20.7M total.
- All nine director nominees elected at May 9 annual meeting; PwC ratified as auditor; say-on-pay approved.
- Board approved transition of Dr. Essig from Executive Chairman to non-executive Chairman effective July 1, 2025; no disagreement.
- Plan amendment eliminates provision allowing shares withheld for taxes to be returned to the plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/917520/000091752025000052/0000917520-25-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/917520/000091752025000052/iart-20250509.htm
  HTML page:      https://secwatch.observer/filing/0000917520-25-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer